Why Is The Iveric Bio (ISEE) Stock Rising More Than 25% Today?
After receiving approval for its innovative medication, Iveric Bio Inc. (Nasdaq: ISEE) saw a 25.87% increase to $21.70 in current market value on Friday. For what therapy did ISEE receive approval? A new investigational complement C5 inhibitor for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD), avacincaptad pegol (ACP, also known […]